Checkmate Pharmaceuticals, Inc.
CMPIDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001651431
Checkmate Pharmaceuticals, Inc. was delisted in 2022; its insiders filed their last Form 4 on May 31, 2022; 26 institutions reported holding it in 13F filings for Q1 2022, worth $54.8M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Checkmate Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −3 vs. Q2 2021
- Shares held
- 16.3M
- −45.4K (−0.3%) vs. Q2 2021
- Total value
- $64.6M
- −$32.7M (−33.6%) vs. Q2 2021
- New holders
- 3
- 6 more added
- Sold out
- 6
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 26 | $54.8M |
| Q4 2021 | 25 | $46.3M |
| Q3 2021 | 31 | $64.6M |
| Q2 2021 | 34 | $97.3M |
| Q1 2021 | 37 | $202.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Checkmate Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| venBio Partners LLC | 3,673,374 | $14.6M | 1.45% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,606,707 | $14.3M | 0.92% | 00.0% | Unchanged |
| Novo Holdings A/S | 2,170,100 | $8.62M | 0.45% | 00.0% | Unchanged |
| Clough Capital Partners L P | 1,567,326 | $6.22M | 0.39% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $5.96M | 1.30% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 1,335,050 | $5.30M | 0.59% | 00.0% | Unchanged |
| FMR LLC | 966,226 | $3.84M | 0.00% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 541,766 | $2.15M | 0.18% | 00.0% | Unchanged |
| Vanguard Group Inc | 336,587 | $1.34M | 0.00% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 119,915 | $476.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 106,500 | $423.0K | 0.01% | +85,000+395.3% | Added |
| RBF Capital, LLC | 68,834 | $273.0K | 0.02% | 00.0% | Unchanged |
| BlackRock Inc. | 51,794 | $205.0K | 0.00% | +28,944+126.7% | Added |
| Cambridge Trust Co | 49,218 | $196.0K | 0.00% | +24,609+100.0% | Added |
| Geode Capital Management, LLC | 40,260 | $159.0K | 0.00% | −120.0% | Reduced |
| Jacobs Levy Equity Management, Inc | 36,511 | $145.0K | 0.00% | +36,511 | New |
| Ergoteles LLC | 25,870 | $103.0K | 0.00% | −557−2.1% | Reduced |
| Federated Hermes, Inc. | 20,000 | $79.0K | 0.00% | +3,831+23.7% | Added |
| HRT Financial LP | 18,298 | $72.0K | 0.00% | −5,823−24.1% | Reduced |
| State Street Corp | 11,087 | $44.0K | 0.00% | +11,087 | New |
| Renaissance Technologies LLC | 10,667 | $42.0K | 0.00% | −12,833−54.6% | Reduced |
| The PNC Financial Services Group, Inc. | 5,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4,120 | $16.0K | 0.00% | +3,728+951.0% | Added |
| Bank of America Corp | 3,370 | $14.0K | 0.00% | −2,961−46.8% | Reduced |
| US Bancorp | 2,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,426 | $6.00K | 0.00% | +1,426 | New |
| JPMorgan Chase & Co | 185 | $1.00K | 0.00% | −4,972−96.4% | Reduced |
| UBS Group AG | 183 | $1.00K | 0.00% | −3,113−94.4% | Reduced |
| Royal Bank of Canada | 168 | $1.00K | 0.00% | −2,219−93.0% | Reduced |
| Johnson Midwest Financial, LLC | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 33 | $0 | 0.00% | +1+3.1% | Added |
| Deutsche Bank AG | 0 | $0 | 0.00% | −134,760−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −40,422−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −7,800−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |